As of 2024-12-15, the Fair Value of Vor Biopharma Inc (VOR) is -8.19 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.99 USD, the upside of Vor Biopharma Inc is -926.13%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -10.84 | -43.34 | -68.90 | -92.09 | -117.86 | -66.61 |
| YoY growth | -161.20% | -299.82% | -58.98% | -33.66% | -27.99% | -116.33% |
| Market Cap (mil) | 68.07 |
| P/E | |
| Forward P/E |
| EPS | -1.64 |
| Avg earnings growth rate | -116.33% |
| TTM earnings | -112.46 |